Free Trial

M&T Bank Corp Has $128.89 Million Position in Corteva, Inc. $CTVA

Corteva logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • M&T Bank Corp trimmed its Corteva stake by 1.9% in Q3 and now owns 1,905,854 shares worth $128.89 million, representing about 0.28% of the company.
  • Corteva set FY2026 guidance at 3.450–3.700 EPS, and analysts carry an average price target of $82.90 with a consensus rating of "Moderate Buy."
  • The company declared a quarterly dividend of $0.18 (annualized $0.72, ~0.9% yield; ex-dividend March 2), while insider Brian Titus sold 8,311 shares, cutting his stake by roughly 50%.
  • MarketBeat previews top five stocks to own in May.

M&T Bank Corp lessened its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 1.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,905,854 shares of the company's stock after selling 37,294 shares during the quarter. M&T Bank Corp owned 0.28% of Corteva worth $128,892,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Activest Wealth Management increased its position in shares of Corteva by 118.3% during the third quarter. Activest Wealth Management now owns 369 shares of the company's stock worth $25,000 after acquiring an additional 200 shares in the last quarter. True Wealth Design LLC lifted its position in Corteva by 209.5% in the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company's stock valued at $26,000 after acquiring an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new position in Corteva during the 2nd quarter valued at about $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva during the 2nd quarter worth approximately $29,000. Finally, Redmont Wealth Advisors LLC bought a new stake in Corteva during the 3rd quarter worth approximately $29,000. 81.54% of the stock is owned by institutional investors.

Corteva Stock Performance

Shares of CTVA opened at $79.13 on Friday. The stock has a 50 day moving average of $74.11 and a 200 day moving average of $69.24. The company has a market capitalization of $53.22 billion, a price-to-earnings ratio of 50.08, a PEG ratio of 2.73 and a beta of 0.72. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $80.90. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts' expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business's revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva's payout ratio is 45.57%.

Analysts Set New Price Targets

CTVA has been the topic of a number of recent research reports. Bank of America raised their target price on Corteva from $80.00 to $82.00 and gave the company a "buy" rating in a report on Thursday, January 8th. CICC Research increased their price target on Corteva from $70.00 to $80.00 and gave the company an "outperform" rating in a research report on Wednesday, February 11th. Zacks Research downgraded shares of Corteva from a "strong-buy" rating to a "hold" rating in a report on Friday, February 20th. Jefferies Financial Group upped their target price on shares of Corteva from $85.00 to $95.00 and gave the stock a "buy" rating in a research note on Monday, March 2nd. Finally, Mizuho increased their target price on shares of Corteva from $80.00 to $82.00 and gave the company an "outperform" rating in a report on Tuesday, February 17th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Corteva has an average rating of "Moderate Buy" and an average price target of $82.90.

Read Our Latest Report on CTVA

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.14% of the company's stock.

About Corteva

(Free Report)

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines